众兴菌业(002772) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 reached ¥567,541,946.40, representing a 13.10% increase year-over-year[5] - Net profit attributable to shareholders was ¥135,328,619.75, a significant increase of 128.70% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥129,596,243.95, up 187.92% year-over-year[5] - Total revenue for the period reached ¥1,475,387,272.68, an increase of 4.8% compared to ¥1,416,478,603.36 in the previous period[24] - Operating profit significantly improved to ¥203,487,370.83, compared to ¥85,679,349.14 in the prior period, marking an increase of 137.5%[24] - The net profit for the current period is approximately ¥203.79 million, compared to ¥87.55 million in the previous period, representing a significant increase[25] - The basic and diluted earnings per share for the current period are both ¥0.5450, up from ¥0.2254 in the previous period, indicating strong earnings growth[25] - The company’s total comprehensive income for the current period is approximately ¥203.79 million, compared to ¥87.55 million in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥6,554,894,972.45, reflecting a 5.88% increase from the end of the previous year[5] - Non-current assets totaled ¥3,603,164,534.52, an increase from ¥3,360,598,436.50, reflecting a growth of approximately 7.2%[22] - Total liabilities rose to ¥3,155,105,541.54 from ¥2,872,170,200.68, indicating an increase of about 9.9%[23] - The company's retained earnings increased to ¥1,049,751,209.81 from ¥957,825,432.49, a rise of approximately 9.6%[23] - The total cash and cash equivalents at the end of the period stand at approximately ¥1.04 billion, down from ¥1.36 billion at the end of the previous period[27] Cash Flow - The company reported a net cash flow from operating activities of ¥293,501,801.90, a decrease of 2.74% year-to-date[5] - Cash flow from operating activities generated a net amount of approximately ¥293.50 million, slightly down from ¥301.78 million in the previous period[26] - Cash inflow from financing activities totaled approximately ¥1.01 billion, while cash outflow was about ¥1.03 billion, resulting in a net cash flow of approximately -¥25.44 million[27] - The company reported a decrease in cash flow from investment activities, with a net cash flow of approximately -¥421.94 million, compared to -¥157.10 million in the previous period[26] Shareholder Information - As of September 30, 2025, Tianshui Zhongxing Fungi Technology Co., Ltd. repurchased 18,498,826 shares, accounting for 4.70% of the total share capital[16] - The top shareholder, Tao Jun, holds 28.01% of the shares, totaling 110,136,094 shares[15] - The second-largest shareholder, Tian De, holds 7.92% of the shares, totaling 31,132,277 shares[15] - The company has no preferred shareholders or significant changes in the top 10 shareholders due to securities lending activities[16] - The company has not disclosed any related party transactions among the top shareholders[15] Corporate Actions - The company completed the registration change procedures on October 15, 2025, and obtained a new business license from the Tianshui Market Supervision Administration[17] - The company approved the 2025 stock option incentive plan on September 25, 2025, and subsequently on October 15, 2025, the plan was authorized for implementation[18] - The company held its third extraordinary general meeting of shareholders on October 15, 2025, to review and approve the stock option incentive plan and related matters[19] - The company’s stock option plan aims to enhance employee motivation and align interests with shareholders[18] Operational Metrics - The weighted average return on net assets was 4.07%, an increase of 2.32 percentage points compared to the same period last year[5] - Financial expenses for the first nine months of 2025 were ¥14,821,357.83, a decrease of 52.63% year-over-year[11] - Investment income for the first nine months of 2025 increased by 443.08% to ¥9,215,161.69 compared to the previous year[11] - The company experienced a 51.59% increase in construction in progress, totaling ¥419,448,847.65, due to new project investments[9] - Short-term borrowings decreased by 54.51% to ¥280,000,000.00, primarily due to the repayment of maturing loans[10] - Total operating costs decreased to ¥1,296,625,652.17 from ¥1,346,770,543.00, reflecting a reduction of approximately 3.7%[24] - Cash and cash equivalents decreased to ¥1,102,483,698.06 from ¥1,191,278,822.28, a decline of about 7.4%[22] - Inventory increased to ¥1,412,131,094.55, up from ¥1,252,358,283.51, representing a growth of approximately 12.8%[22]